↓ Skip to main content

Serum 14-3-3η is a Novel Marker that Complements Current Serological Measurements to Enhance Detection of Patients with Rheumatoid Arthritis

Overview of attention for article published in Journal of Rheumatology, August 2014
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (95th percentile)
  • High Attention Score compared to outputs of the same age and source (98th percentile)

Mentioned by

news
3 news outlets
twitter
11 X users
patent
1 patent
facebook
2 Facebook pages

Citations

dimensions_citation
72 Dimensions

Readers on

mendeley
100 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Serum 14-3-3η is a Novel Marker that Complements Current Serological Measurements to Enhance Detection of Patients with Rheumatoid Arthritis
Published in
Journal of Rheumatology, August 2014
DOI 10.3899/jrheum.131446
Pubmed ID
Authors

Walter P Maksymowych, Stanley J Naides, Vivian Bykerk, Katherine A Siminovitch, Dirkjan van Schaardenburg, Maarten Boers, Robert Landewé, Désirée van der Heijde, Paul-P Tak, Mark C Genovese, Michael E Weinblatt, Edward C Keystone, Olga S Zhukov, Rania W Abolhosn, Joanna M Popov, Karin Britsemmer, Arno W van Kuijk, Anthony Marotta

Abstract

Serum 14-3-3η is a novel joint-derived proinflammatory mediator implicated in the pathogenesis of rheumatoid arthritis (RA). In our study, we assessed the diagnostic utility of 14-3-3η and its association with standard clinical and serological measures.

X Demographics

X Demographics

The data shown below were collected from the profiles of 11 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 100 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 2 2%
Colombia 1 1%
Switzerland 1 1%
Germany 1 1%
Iran, Islamic Republic of 1 1%
Russia 1 1%
Unknown 93 93%

Demographic breakdown

Readers by professional status Count As %
Other 21 21%
Researcher 16 16%
Student > Ph. D. Student 14 14%
Student > Master 9 9%
Student > Doctoral Student 7 7%
Other 14 14%
Unknown 19 19%
Readers by discipline Count As %
Medicine and Dentistry 41 41%
Biochemistry, Genetics and Molecular Biology 12 12%
Agricultural and Biological Sciences 12 12%
Pharmacology, Toxicology and Pharmaceutical Science 4 4%
Immunology and Microbiology 3 3%
Other 6 6%
Unknown 22 22%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 34. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 31 August 2017.
All research outputs
#1,169,042
of 25,374,647 outputs
Outputs from Journal of Rheumatology
#77
of 3,951 outputs
Outputs of similar age
#11,426
of 243,218 outputs
Outputs of similar age from Journal of Rheumatology
#1
of 54 outputs
Altmetric has tracked 25,374,647 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 95th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 3,951 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.4. This one has done particularly well, scoring higher than 98% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 243,218 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 95% of its contemporaries.
We're also able to compare this research output to 54 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 98% of its contemporaries.